Boston Scientific Cardiovascular — Goodwill increased by 0.4% to $10.57B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.1%, from $9.61B to $10.57B. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Goodwill shows an upward trend with a 15.9% CAGR.
An increase suggests recent acquisitions in the cardiovascular space, while a decrease may indicate impairment charges.
Represents the total carrying value of goodwill specifically attributed to the Cardiovascular business segment. This ass...
Commonly reported by medical device peers like Medtronic or Abbott under segment-level intangible assets.
bsx_segment_cardiovascular_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.70B | $5.68B | $5.89B | $8.71B | $8.64B | $8.62B | $8.68B | $9.03B | $9.05B | $9.00B | $9.04B | $9.02B | $9.06B | $9.68B | $9.61B | $9.84B | $10.55B | $10.53B | $10.57B |
| QoQ Change | — | -0.3% | +3.6% | +47.9% | -0.7% | -0.2% | +0.7% | +4.0% | +0.2% | -0.6% | +0.5% | -0.2% | +0.4% | +6.9% | -0.8% | +2.4% | +7.2% | -0.2% | +0.4% |
| YoY Change | — | — | — | — | +51.7% | +51.8% | +47.5% | +3.8% | +4.7% | +4.3% | +4.1% | -0.1% | +0.1% | +7.6% | +6.2% | +9.1% | +16.5% | +8.7% | +10.1% |